Population Pharmacokinetic Study of Amikacin Administered Once or Twice Daily to Febrile, Severely Neutropenic Adults

Once-daily (o.d.) administration of 20 mg of amikacin per kg of body weight to neutropenic patients has been validated by clinical studies, but amikacin pharmacokinetics have been documented only for the 7.5-mg/kg twice-daily (b.i.d.) regimen in this population. In order to determine in neutropenic...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Antimicrob Agents Chemother
Egile Nagusiak:	Tod, Michel, Lortholary, Olivier, Seytre, Delphine, Semaoun, Rémi, Uzzan, Bernard, Guillevin, Loïc, Casassus, Philippe, Petitjean, Olivier
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 1998
Gaiak:	Pharmacology
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105554/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9559795/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.4.849
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!